Kitron ASA

Overview

This report evaluates Kitron ASA (OSE: KIT), a Scandinavian electronics manufacturing services (EMS) company with growing exposure to Defence/Aerospace, using William J. O’Neil’s CAN SLIM framework. It synthesizes company fundamentals, recent results and guidance, competitive context, price/volume behavior, and market conditions to determine an actionable investment stance.

Financial and Business Overview

Business model: Kitron is a leading Nordic EMS provider across Connectivity, Electrification, Industry, Medical Devices, and Defence/Aerospace, operating in Norway, Sweden, Denmark, Lithuania, Germany, Poland, the Czech Republic, India, Malaysia, China and the U.S., with ~2,400–3,000 employees depending on period and source. It manufactures complex electronics from PCBAs to full systems and offers development/industrialization services (kitron.com). Financials: TTM revenue ≈ €638m and TTM net margin ~4.6% (Simply Wall St). FY2024 revenue was €647m (Yahoo Finance); FY2023 revenue was €775m with net profit €51m (Kitron investors). In Q1 2025, revenue was €164.6m (-4% YoY), EBIT €12.5m (+25% YoY), EBIT margin 7.6% vs. 6.1% (Boerse-Express). Order backlog stood at ~€524.6m (+18% YoY), supported by large defence-related wins (Kongsberg, Thales). Guidance: On Apr 2, 2025, Kitron raised FY2025 guidance to revenue €640–710m and EBIT €47–65m (from €600–700m and €42–63m) citing robust defence demand and gradual recovery elsewhere (Yahoo Finance, TipRanks). Balance/valuation: Debt-to-equity ~76% (SWS). Dividend ~NOK 0.35 (yield ~0.6%). At NOK 59.15, market cap ~NOK 11.8bn; trailing P/E ~36.1; price to book reported high due to accounting base; forward P/E (data noise) screens elevated (Yahoo Finance). Execution: Q2 2025 was described as ‘strengthening momentum,’ and the company announced new defence orders in July (Kitron IR).

Market Position & Competitive Advantages

Positioning: Kitron is a top Nordic EMS supplier with differentiated competence in Defence/Aerospace (avionics, radar, comms) and a multi-country footprint that meets localization/offset needs. The structural tailwind is strong: EU/NATO rearmament, procurement harmonization, and SME inclusion are increasing order visibility; Kitron has low ESG risk per Sustainalytics (classified with 10–24.9% of revenue from defence contracting) and is included in OBX ESG (kitron.com; Sustainalytics). Competitive strengths: 1) Defence relationships (e.g., Kongsberg, Thales) with multiple new awards (UAS components €4–8m; airborne radar modules €4m) and program exposure (e.g., NSM/JSM ecosystems). 2) Scale and regional diversification enabling resilience, localization, and tariff/FX mitigation. 3) Rising backlog and improved 2025 guidance. 4) Balanced sector mix beyond defence (medical/industrial/connectivity) for cycle smoothing. Risks (be honest): 1) Valuation risk—trailing P/E ~36 with modest net margins leaves little error margin. 2) Cyclical EMS industry dynamics and customer concentration in defence primes. 3) Execution risk scaling capacity and maintaining quality in defence programs. 4) Macro/FX/tariff volatility; programme timing can shift revenue recognition. 5) Debt/equity ~76% warrants monitoring. 6) Mixed 2024 trend (decline vs 2023) implies the reacceleration is dependent on defence tailwinds materializing on time.

Stock Performance

Price now: NOK 59.15. 52-week range: NOK 28.2–68.1. 52-week performance: +106.6%. 50-DMA ≈ 60.49; 200-DMA ≈ 50.84 (Yahoo Finance). Volume: ~432k 3M avg; ~301k 10D avg. The stock is above its 200-DMA but recently slipped slightly below its 50-DMA, consolidating after a sharp run. From a CAN SLIM lens, the optimal entry would be a breakout to new highs (≥NOK 68.10) on volume at least 40–50% above average, or a high-probability pullback entry supporting at the 50-DMA with tight risk controls.

CAN SLIM Analysis

Conclusion

Kitron’s fundamentals are improving: raised 2025 guidance, expanding defence orders/backlog, rising margins, and leadership-level price performance. However, CAN SLIM’s ‘A’ (annual earnings rise) and ‘M’ (broad market uptrend) are not fully confirmed, and valuation is elevated (trailing P/E ~36) with modest net margins and leverage that argues for disciplined entries. In O’Neil terms, the optimal buy is a breakout to new highs (≥NOK 68.10) on ≥40–50% above-average volume, or a tight-risk support buy if the stock reclaims and holds the 50-DMA with strong accumulation. Until then, maintain a HOLD and be ready to upgrade to BUY on a high-volume breakout; set a stop 7–8% below entry on any new position.